已收录 268921 条政策
 政策提纲
  • 暂无提纲
Long-term Dose Stability of OnabotulinumtoxinA Injection for Adductor Spasmodic Dysphonia: A 19-Year Single Institution Experience
[摘要] ObjectivesAdductor spasmodic dysphonia (AdSD) is a focal dystonia predominantly involving the laryngeal adductor muscles. AdSD is reported to be a largely non-progressive neurological disorder, though fluctuations in symptom severity do occur. Repeated laryngeal onabotulinumtoxinA (BTX-A) injections are the primary management for AdSD. A number of studies have demonstrated long-term dose stability as evidence of this long-term disease stability.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 外科医学
[关键词] laryngeal botox;spasmodic dysphonia;botox dosing;laryngeal dystonia;onabotulinumtoxinA [时效性] 
   浏览次数:10      统一登录查看全文      激活码登录查看全文